Respiratory syncytial virus (RSV) infections in older adults lead to significantly more severe health outcomes and long-term cardiovascular complications compared to other common causes of ...

Respiratory syncytial virus (RSV) is a well-known cause of infections in children, but it's understudied in older individuals. In a retrospective study published in the Journal of the American ...

Respiratory syncytial virus (RSV) is a well-known cause of infections in children, but it's understudied in older individuals.

The NHS in the Black Country is now offering the Respiratory Syncytial Virus (RSV) vaccine at selected local pharmacies, making it easier than ever for eligible groups to get protected.

Respiratory syncytial virus (RSV) infections were associated with significantly increased risk for complications beyond pulmonology, including poor kidney outcomes and cardiovascular conditions ...

Indian pediatric experts report that Respiratory Syncytial Virus (RSV) causes a significant number of infant respiratory infections, yet cases are underreported in India. Despite being a ...

The U.S. Food and Drug Administration expanded its approval of Moderna's respiratory syncytial virus (RSV) vaccine on Thursday to include adults under the age of 60 at increased risk of the ...

The FDA has approved Enflonsia (clesrovimab-cfor) for the prevention of RSV lower respiratory tract disease in neonates and infants who are born during or entering their first RSV season.

The RSV vaccine is one of three vaccines covered under the National Immunisation Program for pregnant women.

Substudy B of the MONeT trial assessed the safety and immunogenicity of Abrysvo in immunocompromised adults at risk of developing severe RSV-associated lower respiratory tract disease.